ENOV vs NBIX · rev $1.17B vs P/E 45, rev $1.77B
Enovis Corp (ENOV) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Enovis Corp (ENOV) is a medical devices company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ENOV revenue for 2026-07-03 was $1.17B. Net income was -$10.0M. Revenue was up 98.9% from 2026-04-03 to 2026-07-03. ENOV currently screens at market cap $1.37B.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ENOV currently screens at market cap $1.37B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ENOV and NBIX stock pages for the full models.
Not investment advice.